Assyro AI

FDA Orange Book · active-ingredient family

Amiloride hydrochloride; hydrochlorothiazide

Amiloride hydrochloride; hydrochlorothiazide is approved as 1 brand and 6 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:MODURETIC 5-50 · NDA 018201

1

Brand (NDA)

6

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
MODURETIC 5-50RLDMERCKNDA 018201Approved Prior to Jan 1, 1982

Generic (ANDA) products (6)

ProductApplicantApplicationTEApproved
AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDECHARTWELL RXANDA 073357Nov 27, 1991
AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDERISINGANDA 073209ABOct 31, 1991
AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEWATSON LABSANDA 073334Jul 19, 1991
HYDRO-RIDEPAR PHARMANDA 070347Dec 25, 1990
AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEBARRANDA 071111ABMay 10, 1988
AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDETEVAANDA 070795Apr 17, 1988

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Amiloride hydrochloride; hydrochlorothiazide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.